Aerovate Therapeutics, Inc. Business Finance Contracts & Agreements

11 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Jade Biosciences, Inc. 2025 Employee Stock Purchase Plan
Equity Distribution Agreements
Aerovate Therapeutics, Inc.
Biotechnology
NV
2025
Jade Biosciences, Inc. Form of Pre-Funded Warrant to Purchase Common Stock (April 28, 2025)
Warrant Agreements
Aerovate Therapeutics, Inc.
Biotechnology
NY
2025
Jade Biosciences, Inc. Restricted Stock Purchase Agreement with Purchaser
Stock Agreements
Aerovate Therapeutics, Inc.
Biotechnology
DE
2024
Jade Biosciences, Inc. 2024 Equity Incentive Plan
Equity Distribution Agreements
Aerovate Therapeutics, Inc.
Biotechnology
DE
2024
Amendment No. 1 to Antibody Discovery and Option Agreement among Paragon Therapeutics, Parade Biosciences Holding, and Jade Biosciences
Modification Agreements
Aerovate Therapeutics, Inc.
Biotechnology
2024
ATM Equity Offering Sales Agreement between Aerovate Therapeutics, Inc. and BofA Securities, Inc. dated April 5, 2023
Equity Distribution Agreements
Aerovate Therapeutics, Inc.
Biotechnology
NY
2023
Description of Securities Registered Under Aerovate Therapeutics, Inc. Charter Documents
Registration Rights Agreements
Aerovate Therapeutics, Inc.
Biotechnology
2022
Underwriting Agreement between Aerovate Therapeutics, Inc. and Jefferies LLC, Cowen and Company, LLC, and Evercore Group L.L.C.
Underwriting Agreements
Aerovate Therapeutics, Inc.
Biotechnology
NY
2021
Common Stock Certificate for Aerovate Therapeutics, Inc.
Stock Agreements
Aerovate Therapeutics, Inc.
Biotechnology
2021
Aerovate Therapeutics Inc. 2018 Equity Incentive Plan
Equity Distribution Agreements
Aerovate Therapeutics, Inc.
Biotechnology
DE
2021
Aerovate Therapeutics Inc. Investors’ Rights Agreement (August 5, 2020)
Investor Rights Agreements
Aerovate Therapeutics, Inc.
Biotechnology
DE
2021